Navigation Links
Pacira Pharmaceuticals, Inc. Reports First Quarter 2011 Financial Results
Date:5/11/2011

nd, parallel group, placebo-controlled bunionectomy trial was presented at the 2011 American Academy of Orthopaedic Surgeons Annual Meeting and the Orthopaedic Research Society's 57th Annual Meeting. The data demonstrated that the median time to first use of opioid rescue medication was 7.2 hours for patients treated with EXPAREL compared with 4.3 hours for patients on placebo (p<0.0001) and that patients treated with EXPAREL had comparable safety in wound healing and significantly improved efficacy in pain reduction compared to patients treated with placebo.  
  • Completed an IPO:  On February 8, 2011, Pacira sold an aggregate of 6 million shares of its common stock at $7.00 per share resulting in 2011 net proceeds of approximately $37 million.
  • Presented new Phase 1 study data on subjects with hepatic impairment: In March 2011, data from Pacira's Phase 1 study evaluating EXPAREL in subjects with moderate, stable hepatic impairment was presented at the 2011 American Society for Clinical Pharmacology and Therapeutics 112th Annual Meeting. Results from the Phase 1 open-label, parallel group volunteer study demonstrated that the differences in plasma exposure of EXPAREL between subjects with moderate, stable hepatic impairment compared to subjects with normal hepatic function were small and unlikely to require a dose adjustment of EXPAREL.
  • Presented new preclinical study data on the administration of EXPAREL via peripheral nerve block and on the compatibility of EXPAREL with Lidocaine: In April 2011, new data from two preclinical studies were presented at the Experimental Biology 2011 Annual Meeting. Results from the two preclinical studies demonstrated that EXPAREL was safe when administered in animals as peripheral nerve block and that EXPAREL may be locally administered after waiting 20 minutes following local administration of lidocaine, without potential for an interaction. Additional studies are underway to
    '/>"/>

  • SOURCE Pacira Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10

    Related medicine technology :

    1. Pacira Pharmaceuticals, Inc. Announces EXPAREL™ Data Presentations
    2. Pacira Pharmaceuticals, Inc. Announces Timing for First Quarter 2011 Financial Results Webcast and Conference Call
    3. Pacira Pharmaceuticals to Present at BioCentury Future Leaders in the Biotech Industry Conference
    4. Pacira Pharmaceuticals Reports Fourth Quarter and 2010 Financial Results
    5. Pacira Pharmaceuticals to Present at the Barclays Capital 2011 Global Healthcare Conference
    6. Pacira Pharmaceuticals EXPAREL™ Data to be Featured at 2011 ASCPT 112th Annual Meeting
    7. Pacira Pharmaceuticals Highlights Additional Safety Data on EXPAREL™ for Postsurgical Pain Relief at 2011 American Academy of Orthopaedic Surgeons Annual Meeting
    8. Pacira Pharmaceuticals, Inc. Announces Pricing of Its Initial Public Offering
    9. Pacira Pharmaceuticals Presents New Data from EXPAREL Phase 3 Study at Orthopaedic Research Societys 57th Annual Meeting
    10. Pacira Pharmaceuticals Announces FDA Acceptance of EXPAREL™ New Drug Application for Pain Management
    11. Phase III Studies of EXPAREL(TM) (DepoBupivacaine) from Pacira Complete Enrollment
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/4/2015)... Research and Markets ( ... "Stability Testing of Pharmaceuticals (London, UK - December 2-3, ... attending this comprehensive two day seminar delegates will: ... that are suitable for global arketing - Be ... stability samples and facilities - Know how to ...
    (Date:9/4/2015)... VANCOUVER, British Columbia and MENLO ... DelMar Pharmaceuticals, Inc. (OTCQX: DMPI) ("DelMar" and the ... commercialization of new cancer therapies, today announced its financial ... and provided an overview of recent Company highlights and ... will host a business update conference call and live ...
    (Date:9/3/2015)... , Sept. 3, 2015  Cipla, a global pharmaceutical ... everyday needs of all patients, today announced that its ... to acquire two US-based companies, InvaGen Pharmaceuticals Inc., and ... closing conditions, is valued at $550 million and will ... these transactions is over $200 million for the year ...
    Breaking Medicine Technology:Stability Testing of Pharmaceuticals: 2 Day Seminar - London, UK - December 2-3, 2015 2DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 2DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 3DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 4DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 5DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 6DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 7DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 8Cipla to acquire 100% of generic businesses in US for $550M 2Cipla to acquire 100% of generic businesses in US for $550M 3Cipla to acquire 100% of generic businesses in US for $550M 4Cipla to acquire 100% of generic businesses in US for $550M 5
    ... Latvia, Oct. 14 Doctors in Latvia ... radiosurgery platform from Varian Medical Systems (NYSE: VAR ... treated using Varian,s RapidArc® radiotherapy technology at the Riga ... radiosurgery platform together with RapidArc technology enabled the clinicians ...
    ... Oct. 14 The exhibit hall at AdvaMed 2009 ... Convention Center is brimming with displays of cutting edge ... and development in the MedTech industry, and innovative devices ... people all over the world. The dynamic hall ...
    Cached Medicine Technology:Eastern Europe's First Novalis Tx(TM) Radiosurgery Platform Begins Radiotherapy Treatments in Latvia using RapidArc(R) Technology 2Eastern Europe's First Novalis Tx(TM) Radiosurgery Platform Begins Radiotherapy Treatments in Latvia using RapidArc(R) Technology 3Vibrant Exhibit Hall Features Innovative Medical Technology at AdvaMed 2009 2
    (Date:9/4/2015)... ... ... IVF New England, one of the largest and most successful fertility centers ... for women who wish to learn more about their fertility and egg freezing. , ... Elm Street, Manchester, NH from 6PM to 7PM , This hip, casual and informative ...
    (Date:9/4/2015)... ... September 04, 2015 , ... ... benefit Core Compassion Project. Core Compassion Project is a non-profit organization dedicated ... reduce the side effects of cancer treatments and recover their mobility, strength, and ...
    (Date:9/4/2015)... Wailea, Maui HI (PRWEB) , ... September 04, 2015 , ... ... of the best ways for couples to explore, revitalize and strengthen their ‘couple-ness,’” ... Wietzel and his team at Four Seasons Resort Maui, the island’s only Forbes Five ...
    (Date:9/4/2015)... ... September 04, 2015 , ... The USC Eye Institute is proud to ... by Doximity. Faculty, residents and staff are honored to have contributed to the ... of our ophthalmology residency program. Our faculty places a high priority on our educational ...
    (Date:9/4/2015)... York, NY (PRWEB) , ... September 04, 2015 , ... ... meters qualifying heat, and followed up with victory in the men’s 400 meters final, ... (NACAC) Senior Track and Field Championships in San Jose, Costa Rica in August 2015. ...
    Breaking Medicine News(10 mins):Health News:IVF New England to Host ManchVegas New Hampshire Fertility Happy Hour on October 15, 2015 in Manchester for Women Who Wish to Learn More About Fertility and Egg Freezing 2Health News:Girl’s Night Out to Benefit Core Compassion Project, Located at the Beautiful, Morning Glory Farm 2Health News:Couples Season at Four Seasons Resort Maui Begins This Week With Best Hotel Rates of the Year through November 2Health News:Couples Season at Four Seasons Resort Maui Begins This Week With Best Hotel Rates of the Year through November 3Health News:USC Ophthalmology Residency Program Ranked in Top 10 by Doximity 2Health News:USC Ophthalmology Residency Program Ranked in Top 10 by Doximity 3Health News:Lalonde Gordon’s Recipe Brings Home the Gold 2Health News:Lalonde Gordon’s Recipe Brings Home the Gold 3
    ... a new tool to understand how cancers grow -- and ... They,ve been able to break apart human prostate tissue, extract ... genetically so that they spur cancer. Owen Witte, a ... Los Angeles, will present the findings on February 20, 2010, ...
    ... Sciences Research convenes a panel discussion, "Science in ... Topics will include:, Recommendations from Beyond Health ... Wood Johnson Foundation Commission to Build a Healthier ... approaches can inform public policy, How science-informed policy ...
    ... ... of "Sun Spark Purity" the company has already positioned itself as a powerful player in ... clients smaller quantities and samples that can be purchased via creditcards! , ... (PRWEB) February 20, 2010 -- The war is ...
    ... "Earth system" was, until recently, composed of several large-scale ... For example, atmospheric activity and carbon and phosphorus cycles ... 100 years or so, however, many human activities have ... the old equilibriums off-kilter. "Humans have, essentially, ...
    ... ... scientist and the leading voice of the stem cell revolution, is on a 10 city ... , ... 2010 -- Remarkable public interest in the stem cell phenomenon made a science book an ...
    ... , ... ... ... ...
    Cached Medicine News:Health News:New tool illuminates connections between stem cells and cancer 2Health News:Sun Spark Purity Moves Aggressively into the Market of Pure Lidocaine Powder and Caffeine Powder 2Health News:Sun Spark Purity Moves Aggressively into the Market of Pure Lidocaine Powder and Caffeine Powder 3Health News:Arizona State University's Decision Theater offers balance to an off-kilter world 2Health News:Health: Surprise Best Seller is Stem Cell Book &#8211; Author in Spokane - 10 City Tour 2Health News:Idaho Legislators Stand for Health Care Freedom 2Health News:Idaho Legislators Stand for Health Care Freedom 3Health News:Idaho Legislators Stand for Health Care Freedom 4
    ... complete line of Surgical Access ...unlike any ... OnePort™ trocar system is actually four systems ... operationally flexible and clinically adaptive to all ... in disposability and bladed or dilating tip ...
    Mini-Finesse 5mm Dilating Trocar, hook electrode, two lengths, mini or basic kit....
    ... The Thoracic Trocar Sleeve consists ... which is designed to prevent ... structures once the cavity has ... stability threads on the sleeve ...
    ... The TRISTAR is a full-featured trocar that consists ... The shield is designed to cover the pyramidal ... laceration once the abdominal or thoracic cavity has ... excessive force to insert is not required. , ...
    Medicine Products: